The News CartelThe News Cartel
    What's Hot

    Top 7 Restaurant Furniture Manufacturers in India

    July 1, 2025

    Vishwa Samudra Group Named Among ET Now’s “Best Organisations to Work 2025”

    July 1, 2025

    “India Was, Is, And Will Remain A Maritime Nation”: Naval Chief Inspires Future Leaders At IIM Rohtak

    July 1, 2025
    Facebook Twitter Instagram
    The News CartelThe News Cartel
    • Home
    • News
      • Business
      • Education
      • Entertainment
      • Health
      • National
      • Lifestyle
      • Technology
      • World
    The News CartelThe News Cartel
    Home»National»Lords Mark Microbiotech Pvt. Limited receives Mid-Day Health & Wellness Icon Award for Best Preventive Genetic Testing
    National

    Lords Mark Microbiotech Pvt. Limited receives Mid-Day Health & Wellness Icon Award for Best Preventive Genetic Testing

    Shruti JoshiBy Shruti JoshiJune 27, 2024No Comments3 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Mumbai (Maharashtra) [India], June 27: Lords Mark Microbiotech Pvt. Limited, a subsidiary of Lords Mark Industries Limited, a distinguished company known for its diverse portfolio, was honoured with the Mid-Day Health & Wellness Icon Award in the category of Best Preventive Genetic Testing across India. The prestigious ceremony took place at the Sahara Star, Ville Parle in Mumbai where industry leaders and achievers were recognized for their outstanding contributions in the health and wellness sector.

    Mr. Subodh Gupta, CEO of Lords Mark Microbiotech Pvt. Limited, was presented with the esteemed award by Bollywood Actress Bhagyashree and Actress & Model Miss Mugdha Godse. The event was also graced by the presence of esteemed dignitaries from the renowned healthcare institutes.

    Commenting on the occasion, Mr. Subodh Gupta, CEO of Lords Mark Microbiotech Pvt. Limited said, “We are truly privileged and extremely proud to receive this award. With the introduction of saliva-based technology for genome testing through our brand MyDNA which results 99% accuracy, we will focus on preventive Genomic testing for early detection, screening, and personalised interventions for diseases such as cancer, cardiovascular disorders, diabetes, or hereditary condition. We’re committed to driving innovation and technology delivering impactful solutions that benefit common people or masses. This recognition fuels our passion to continue pushing boundaries and contributing to the advancement of the healthcare industry. “ 

    Lord’s Mark Microbiotech, at the forefront of this industry, has been tirelessly working to develop innovative solutions that offer more comprehensive and accurate results than ever before and has invested significant resources in researching and developing a state-of-the-art genomic testing technology that combines advanced bioinformatics, machine learning, and microbiome analysis. This unique approach allows for a deeper understanding of the complex relationship between an individual’s genetics and their microbiota, leading to precise and personalized healthcare recommendations.  

    About Lord’s Mark Microbiotech Pvt. Ltd:

    Lords Mark Microbiotech Pvt. Limited, a subsidiary of Lords Mark Industries Limited, specifically working for preventive genome testing which are saliva- based test and do not require extraction of blood or the need of a phlebotomist. It can be done by an individual after reading the enclosed instructions in the kit at their home as well. By exploring the intricate connections between human genetics and the microbiome, Lord’s Microbiotech has successfully identified key genetic markers associated with various health conditions, including autoimmune disorders, metabolic diseases, and even mental health issues.

    Their breakthrough research has the potential to reshape how they diagnose, treat, and prevent diseases, ultimately improving the lives of millions worldwide. Lord’s Mark Microbiotech commitment to scientific excellence is matched by their dedication to accessibility and affordability. They are actively working on optimizing their genomic testing platform to make it more accessible to healthcare providers, researchers, and ultimately, the general public. Lords Mark Micro Biotech are currently testing for 8 conditions in preventive testing specially in the area of chronic illness like CVD, Diabetes and Cancer and the company look forward to expand that soon.

    Website –  https://mydna.lordsmicrobiotech.com/aboutus 

    If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    National
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleUneecops Accomplishes 75 Plus SAP ERP Go-Lives in FY 2023-24,Sets New Benchmark
    Next Article Kaveesh Mehta and Abraham (Abe) Lee, a 22-Year-Young NYU Graduates Launch FEELINGS: A Revolutionary Fashion Brand
    Shruti Joshi
    • Website

    Related Posts

    ABS Marine Announces Major Operational Updates

    July 1, 2025

    Over 4,500 Runners Unite for Panchshil Soldierathon Bombay Sappers: A Stirring Salute to the Indian Armed Forces

    July 1, 2025

    India’s Innovation Juggernaut: 10 Startups Turning Bold Ideas into Currency

    June 28, 2025
    Add A Comment

    Comments are closed.

    Top Posts

    Subscribe to Updates

    Get the latest sports news from SportsSite about soccer, football and tennis.

    [fluentform id="4"]
    Advertisement
    Facebook Twitter Instagram Pinterest YouTube
    Top Insights
    Get Informed

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    [fluentform id="4"]
    © 2025 The News Cartel.
    • Home

    Type above and press Enter to search. Press Esc to cancel.